Advertisement

Amyotrophic Lateral Sclerosis and Motor Neuron Disease

  • Maggie A. KuhnEmail author
  • Lisa Marie Williams
Chapter
  • 57 Downloads

Abstract

Motor neuron diseases (MNDs) are progressive neurodegenerative disorders affecting spinal and bulbar nerves. Of this class of diseases, amyotrophic lateral sclerosis (ALS) is the most common. Other MNDs differ in age of onset, distribution of motor neuron involvement, and disease severity. Most occur sporadically and have no clear cause, while a minority are inherited. All share an unrelenting course without known cure and commonly impair communication, deglutition, and respiration. They universally create significant impact to patient’s quality of life, nutritional status, and longevity. Treatments focus on managing symptoms and preventing adverse sequelae related to neurologic deficits.

Keywords

Amyotrophic lateral sclerosis Hereditary spastic paraparesis Lower motor neuron Motor neuron disease Primary lateral sclerosis Progressive bulbar palsy Progressive muscular atrophy Spinal and bulbar muscular atrophy Spinal muscular atrophy Upper motor neuron 

References

  1. 1.
    Vesey S. The challenges of dysphagia in treating motor neurone disease. Br J Community Nurs. 2017;22(Suppl 7):S17–21.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Luchesi KF, Kitamua S, Mourão LF. Amyotrophic lateral sclerosis survival analysis: swallowing and non-oral feeding. Neuro Rehabilitation. 2014;35(3):535–42.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Nakamori M, Hosomi N, Takaki S, Oda M, Hiraoka A, Yoshikawa M, et al. Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients. Clin Neurophysiol. 2016;127(2):1669–74.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22(4):217–28.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    National Institute of Neurological Disorders and Stroke. Motor Neuron Diseases Information Page. Date last modified: 27 Mar 2019. https://www.ninds.nih.gov/Disorders/All-Disorders/Motor-Neuron-Diseases-Information-Page. Accessed 19 Jun 2019.
  6. 6.
    Rowland LP. How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol. 2001;58(3):512–5.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Riva N, Agosta F, Lunetta C, et al. Neurological update: recent advances in amyotrophic lateral sclerosis. Neurology. 2016;263:1241–54.CrossRefGoogle Scholar
  8. 8.
    Murono S, Hamaguchi T, Yoshida H, Nakanishi Y, Tsuji A, Endo K, et al. Evaluation of dysphagia at the initial diagnosis of amyotrophic lateral sclerosis. Auris Nasus Larynx. 2015;42(3):213–7.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Finsterer J, Soraru G. Onset manifestations of spinal and bulbar muscular atrophy (Kennedy’s Disease). J Mol Neurosci. 2016;58(3):321–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    MacLean HE, Warne GL, Zajac JD. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion. J Neurol Sci. 1996;135(2):149–57.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Fink JK. Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol. 2001;21(2):199–207.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131(Pt 3):772–84.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Fink JK. Hereditary spastic paraplegia. Curr Neurol Neurosci Rep. 2006;6(1):65–76.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Mannan AU, Krawen P, Sauter SM, Boehm J, Chronowska A, Paulus W, et al. ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet. 2006;79(2):351–7.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rubin AD, Griffin GR, Hogikyan ND, Feldman EL. A new member of the multidisciplinary ALS team: the otolaryngologist. Amyotroph Lateral Scler. 2012;13(2):229–32.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler. 2011;12(1):1–10.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Chen A, Garrett CG. Otolaryngologic presentations of amyotrophic lateralsclerosis. Otolaryngol Head Neck Surg. 2005;132(3):500–4.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225–38.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 1999;72(6):2415–25.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156(1):65–72.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    D’Amico E, Pasmantier M, Lee YW, Weimer L, Mitsumoto H. Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD). Muscle Nerve. 2013;47(1):28–32.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Valadi N. Evaluation and management of amyotrophic lateral sclerosis. Prim Care. 2015;42(2):177–87.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Mayberry JF, Atkinson M. Swallowing problems in patients with motor neuron disease. J Clin Gastroenterol. 1986;8(3 Pt 1):233–4.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50(1):66–72.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Motor Neuron Disease Association, Northampton, United Kingdom. Cognitive change and frontotemporal dementia. Updated Jun 2019. http://bit.ly/2rJc0w4. Accessed 19 Jun 2019.
  26. 26.
    Cohen SM, Elackattu A, Noordzij JP, Walsh MJ, Langmore SE. Palliative treatment of dysphonia and dysarthria. Otolaryngol Clin N Am. 2009;42(1):107–21, x.CrossRefGoogle Scholar
  27. 27.
    Kühnlein P, Gdynia HJ, Sperfeld AD, Lindner-Pfleghar B, Ludolph AC, Prosiegel M, et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008;4(7):366–74.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Leighton SE, Burton MJ, Lund WS, Cochrane GM. Swallowing in motor neurone disease. J R Soc Med. 1994;87(12):801–5.PubMedPubMedCentralGoogle Scholar
  29. 29.
    van den Engel-Hoek L, Erasmus CE, van Bruggen HW, de Swart BJ, Sie LT, Steenks MH, et al. Dysphagia in spinal muscular atrophy type II: more than a bulbar problem? Neurology. 2009;73(21):1787–91.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    R W, M I, M H, J S. M H. primary lateral sclerosis. Neuropathology. 1997;17(3):220–4.CrossRefGoogle Scholar
  31. 31.
    Szacka K, Potulska-Chromik A, Fronczewska-Wieniawska K, Spychała A, Kròlicki L, Kuźma-Kozakiewicz M. Scintigraphic evaluation of mild to moderate dysphagia in motor neuron disease. Clin Nucl Med. 2016;41(4):e175–80.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Cerero Lapiedra R, Moreno López LA, Esparza Gómez GC. Progressive bulbar palsy: a case report diagnosed by lingual symptoms. J Oral Pathol Med. 2002;31(5):277–9.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Amin MR, Harris D, Cassel SG, Grimes E, Heiman-Patterson T. Sensory testing in the assessment of laryngeal sensation in patients with amyotrophic lateral sclerosis. Ann Otol Rhinol Laryngol. 2006;115(7):528–34.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9(1):59–62.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1–2):13–21.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Brandão RKC, de Carvalho GGP, Silva RR, Dias DLS, Mendes FBL, Lins TOJD, et al. Correlation between production performance and feeding behavior of steers on pasture during the rainy-dry transition period. Trop Anim Health Prod. 2018;50(1):105–11.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining swallowing-related quality of life profiles in individuals with amyotrophic lateral sclerosis. Dysphagia. 2016;31(3):376–82.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Waito AA, Valenzano TJ, Peladeau-Pigeon M, Steele CM. Trends in research literature describing dysphagia in motor neuron diseases (MND): a scoping review. Dysphagia. 2017;32(6):734–47.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A, et al. Swallowing markers in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol. 2017;4(8):534–43.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Fattori B, Siciliano G, Mancini V, Bastiani L, Bongioanni P, Caldarazzo Ienco E, et al. Dysphagia in amyotrophic lateral sclerosis: relationships between disease progression and fiberoptic endoscopic evaluation of swallowing. Auris Nasus Larynx. 2017;44(3):306–12.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Plowman EK, Watts SA, Robison R, Tabor L, Dion C, Gaziano J, et al. Voluntary cough airflow differentiates safe versus unsafe swallowing in amyotrophic lateral sclerosis. Dysphagia. 2016;31(3):383–90.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Barber C. Management of bulbar symptoms in motor neurone disease: a community speech and language therapist perspective. Br J Neurosci Nursing. 2015;11(1):41–6.CrossRefGoogle Scholar
  43. 43.
    Beukelman DR, Fager S, Ball L, Dietz A. AAC for adults with acquired neurological conditions: a review. Augment Altern Commun. 2007;23(3):230–42.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Plowman EK, Watts SA, Tabor L, Robison R, Gaziano J, Domer AS, et al. Impact of expiratory strength training in amyotrophic lateral sclerosis. Muscle Nerve. 2016;54(1):48–53.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Kübler A, Nijboer F, Mellinger J, Vaughan TM, Pawelzik H, Schalk G, et al. Patients with ALS can use sensorimotor rhythms to operate a brain-computer interface. Neurology. 2005;64(10):1775–7.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Group PS. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol. 2015;14(7):702–9.CrossRefGoogle Scholar
  47. 47.
    Chiò A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology. 1999;53(5):1123–5.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(3):177–85.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2011;1:CD004030.Google Scholar
  50. 50.
    Chhetri SK, Bradley BF, Majeed T, Lea RW. Enteral feeding in motor neurone disease: Patients’ perspectives and impact on quality of life. Palliat Med. 2017;31(7):676–7.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401–8.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Vianello A, Arcaro G, Palmieri A, Ermani M, Braccioni F, Gallan F, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care. 2011;26(3):329.e7–14.CrossRefGoogle Scholar
  53. 53.
    Garvey CM, Boylan KB, Salassa JR, Kennelly KD. Total laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(5–6):470–5.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Geevasinga N, Menon P, Scherman DB, Simon N, Yiannikas C, Henderson RD, et al. Diagnostic criteria in amyotrophic lateral sclerosis: a multicenter prospective study. Neurology. 2016;87(7):684–90.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Otolaryngology–Head and Neck SurgeryUniversity of California, DavisSacramentoUSA
  2. 2.Department of Physical Medicine and RehabilitationUniversity of California, DavisSacramentoUSA

Personalised recommendations